Self-Amplifying Replicon RNA Delivery to Dendritic Cells by Cationic Lipids

McCullough, 2012, Functional RNA delivery targeted to dendritic cells by synthetic nanoparticles, Ther. Deliv., 3, 1077, 10.4155/tde.12.90 Démoulins, 2016, Polyethylenimine-based polyplex delivery of self-replicating RNA vaccines, Nanomedicine (Lond.), 12, 711, 10.1016/j.nano.2015.11.001 McCullough, 2014, Self-replicating Replicon-RNA Delivery to Dendritic Cells by Chitosan-nanoparticles for Translation In Vitro and In Vivo, Mol. Ther. Nucleic Acids, 3, e173, 10.1038/mtna.2014.24 Tratschin, J.D., Ruggli, N., and McCullough, K.C. (2008). Pestivirus replicons providing an RNA-based viral vector system. US patent application publication 20160108372 A1, filed December 22, 2015, and published April 21, 2016. Brito, 2014, A cationic nanoemulsion for the delivery of next-generation RNA vaccines, Mol. Ther., 22, 2118, 10.1038/mt.2014.133 Geall, 2012, Nonviral delivery of self-amplifying RNA vaccines, Proc. Natl. Acad. Sci. USA, 109, 14604, 10.1073/pnas.1209367109 Brazzoli, 2015, Induction of Broad-Based Immunity and Protective Efficacy by Self-amplifying mRNA Vaccines Encoding Influenza Virus Hemagglutinin, J. Virol., 90, 332, 10.1128/JVI.01786-15 Atkins, 2008, Therapeutic and prophylactic applications of alphavirus vectors, Expert Rev. Mol. Med., 10, e33, 10.1017/S1462399408000859 Khromykh, 2000, Replicon-based vectors of positive strand RNA viruses, Curr. Opin. Mol. Ther., 2, 555 Pijlman, 2006, Kunjin virus replicons: an RNA-based, non-cytopathic viral vector system for protein production, vaccine and gene therapy applications, Expert Opin. Biol. Ther., 6, 135, 10.1517/14712598.6.2.135 Rayner, 2002, Alphavirus vectors and vaccination, Rev. Med. Virol., 12, 279, 10.1002/rmv.360 Suter, 2011, Immunogenic and replicative properties of classical swine fever virus replicon particles modified to induce IFN-α/β and carry foreign genes, Vaccine, 29, 1491, 10.1016/j.vaccine.2010.12.026 Ljungberg, 2015, Self-replicating alphavirus RNA vaccines, Expert Rev. Vaccines, 14, 177, 10.1586/14760584.2015.965690 McCullough, 2015, Dendritic Cell Targets for Self-Replicating RNA Vaccines, J. Blood Lymph, 5, 132 McCullough, 2014, Self-amplifying replicon RNA vaccine delivery to dendritic cells by synthetic nanoparticles, Vaccines (Basel), 2, 735, 10.3390/vaccines2040735 Mellman, 2001, Dendritic cells: specialized and regulated antigen processing machines, Cell, 106, 255, 10.1016/S0092-8674(01)00449-4 Steinman, 2002, Exploiting dendritic cells to improve vaccine efficacy, J. Clin. Invest., 109, 1519, 10.1172/JCI0215962 Kumari, 2010, Endocytosis unplugged: multiple ways to enter the cell, Cell Res., 20, 256, 10.1038/cr.2010.19 Platta, 2011, Endocytosis and signaling, Curr. Opin. Cell Biol., 23, 393, 10.1016/j.ceb.2011.03.008 Luo, 2000, Synthetic DNA delivery systems, Nat. Biotechnol., 18, 33, 10.1038/71889 Lundstrom, 2016, Replicon RNA Viral Vectors as Vaccines, Vaccines (Basel), 4, E39, 10.3390/vaccines4040039 Andries, 2015, Synthetic biology devices and circuits for RNA-based ‘smart vaccines’: a propositional review, Expert Rev. Vaccines, 14, 313, 10.1586/14760584.2015.997714 Rodríguez-Gascón, 2014, Development of nucleic acid vaccines: use of self-amplifying RNA in lipid nanoparticles, Int. J. Nanomedicine, 9, 1833, 10.2147/IJN.S39810 Zelphati, O., and Moutard, S. (2009). New class of cationic lipids for transporting active agents into cells. US patent application publication US20120015865 A1, filed February 16, 2011, and published January 19, 2012. Zelphati, 1996, Mechanism of oligonucleotide release from cationic liposomes, Proc. Natl. Acad. Sci. USA, 93, 11493, 10.1073/pnas.93.21.11493 Hattori, 2015, siRNA delivery into tumor cells by cationic cholesterol derivative-based nanoparticles and liposomes, Biol. Pharm. Bull., 38, 30, 10.1248/bpb.b14-00526 Auray, 2016, Characterization and Transcriptomic Analysis of Porcine Blood Conventional and Plasmacytoid Dendritic Cells Reveals Striking Species-Specific Differences, J. Immunol., 197, 4791, 10.4049/jimmunol.1600672 Link, 2004, The Toll-like receptor ligand MALP-2 stimulates dendritic cell maturation and modulates proteasome composition and activity, Eur. J. Immunol., 34, 899, 10.1002/eji.200324511 Borsutzky, 2003, Efficient mucosal delivery of the HIV-1 Tat protein using the synthetic lipopeptide MALP-2 as adjuvant, Eur. J. Immunol., 33, 1548, 10.1002/eji.200323954 Rharbaoui, 2002, The Mycoplasma-derived lipopeptide MALP-2 is a potent mucosal adjuvant, Eur. J. Immunol., 32, 2857, 10.1002/1521-4141(2002010)32:10<2857::AID-IMMU2857>3.0.CO;2-R García-Sastre, 2013, Novel vaccine strategies against emerging viruses, Curr. Opin. Virol., 3, 210, 10.1016/j.coviro.2013.02.001 Aronsohn, 1998, Nuclear localization signal peptides enhance cationic liposome-mediated gene therapy, J. Drug Target., 5, 163, 10.3109/10611869808995871 Brisson, 1999, Subcellular trafficking of the cytoplasmic expression system, Hum. Gene Ther., 10, 2601, 10.1089/10430349950016645 Lundstrom, 2002, Alphavirus-based vaccines, Curr. Opin. Mol. Ther., 4, 28 Zimmer, 2010, RNA replicons - a new approach for influenza virus immunoprophylaxis, Viruses, 2, 413, 10.3390/v2020413 Mintzer, 2009, Nonviral vectors for gene delivery, Chem. Rev., 109, 259, 10.1021/cr800409e Tros de Ilarduya, 2010, Gene delivery by lipoplexes and polyplexes, Eur. J. Pharm. Sci., 40, 159, 10.1016/j.ejps.2010.03.019 Belizaire, 2009, Targeting proteins to distinct subcellular compartments reveals unique requirements for MHC class I and II presentation, Proc. Natl. Acad. Sci. USA, 106, 17463, 10.1073/pnas.0908583106 Granot, 2017, Delivering the right message: Challenges and opportunities in lipid nanoparticles-mediated modified mRNA therapeutics-An innate immune system standpoint, Semin. Immunol., 34, 68, 10.1016/j.smim.2017.08.015 Riley, 2017, Recent Advances in Nanomaterials for Gene Delivery-A Review, Nanomaterials (Basel), 7, E94, 10.3390/nano7050094 Cullis, 2017, Lipid Nanoparticle Systems for Enabling Gene Therapies, Mol. Ther., 25, 1467, 10.1016/j.ymthe.2017.03.013 Jiang, 2017, Extracellular vesicles for nucleic acid delivery: progress and prospects for safe RNA-based gene therapy, Gene Ther., 24, 157, 10.1038/gt.2017.8 Guan, 2017, Nanotechnologies in delivery of mRNA therapeutics using nonviral vector-based delivery systems, Gene Ther., 24, 133, 10.1038/gt.2017.5 Hughes, 2005, Nanostructure-mediated drug delivery, Nanomedicine, 1, 22, 10.1016/j.nano.2004.11.009 Rao, 2006, Cell biological and biophysical aspects of lipid-mediated gene delivery, Biosci. Rep., 26, 301, 10.1007/s10540-006-9026-8 Tresset, 2009, The multiple faces of self-assembled lipidic systems, PMC Biophys., 2, 3, 10.1186/1757-5036-2-3 Dan, 2014, Structure and kinetics of lipid-nucleic acid complexes, Adv. Colloid Interface Sci., 205, 230, 10.1016/j.cis.2014.01.013 Caracciolo, 2005, Multicomponent cationic lipid-DNA complex formation: role of lipid mixing, Langmuir, 21, 11582, 10.1021/la052077c Oberle, 2000, Lipoplex formation under equilibrium conditions reveals a three-step mechanism, Biophys. J., 79, 1447, 10.1016/S0006-3495(00)76396-X Hsu, 2005, Mesomorphic complexes of DNA with the mixtures of a cationic surfactant and a neutral lipid, Langmuir, 21, 9426, 10.1021/la051863e Wasungu, 2006, Cationic lipids, lipoplexes and intracellular delivery of genes, J. Control. Release, 116, 255, 10.1016/j.jconrel.2006.06.024 Schijns, 2005, Vaccine adjuvant technology: from theoretical mechanisms to practical approaches, Dev. Biol. (Basel), 121, 127 Nimmerjahn, 2005, Divergent immunoglobulin g subclass activity through selective Fc receptor binding, Science, 310, 1510, 10.1126/science.1118948 Kawaguchi, 2004, IL-17 cytokine family, J. Allergy Clin. Immunol., 114, 1265, 10.1016/j.jaci.2004.10.019 Kawaguchi, 2004, Induction of granulocyte-macrophage colony-stimulating factor by a new cytokine, ML-1 (IL-17F), via Raf I-MEK-ERK pathway, J. Allergy Clin. Immunol., 114, 444, 10.1016/j.jaci.2004.03.047 Lin, 2010, Th17 cytokines and vaccine-induced immunity, Semin. Immunopathol., 32, 79, 10.1007/s00281-009-0191-2 Démoulins, 2017, Self-replicating RNA vaccine delivery to dendritic cells, Methods Mol. Biol., 1499, 37, 10.1007/978-1-4939-6481-9_3 Ruggli, 1996, Nucleotide sequence of classical swine fever virus strain Alfort/187 and transcription of infectious RNA from stably cloned full-length cDNA, J. Virol., 70, 3478, 10.1128/jvi.70.6.3478-3487.1996 Feng, 2004, Nanoparticles of biodegradable polymers for new-concept chemotherapy, Expert Rev. Med. Devices, 1, 115, 10.1586/17434440.1.1.115 Petri, 2007, Chemotherapy of brain tumour using doxorubicin bound to surfactant-coated poly(butyl cyanoacrylate) nanoparticles: revisiting the role of surfactants, J. Control. Release, 117, 51, 10.1016/j.jconrel.2006.10.015 Champion, 2007, Particle shape: a new design parameter for micro- and nanoscale drug delivery carriers, J. Control. Release, 121, 3, 10.1016/j.jconrel.2007.03.022 Ebensen, 2011, Bis-(3′,5′)-cyclic dimeric adenosine monophosphate: strong Th1/Th2/Th17 promoting mucosal adjuvant, Vaccine, 29, 5210, 10.1016/j.vaccine.2011.05.026